| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Air and surface sampling for monkeypox virus in a UK hospital: an observational study
|
Gould, Susan
|
|
|
|
12 |
p. e904-e911
|
artikel
|
| 2 |
Antimicrobial resistance is part of a perfect storm of health crises
|
The Lancet Microbe,
|
|
|
|
12 |
p. e645
|
artikel
|
| 3 |
Antimicrobial susceptibility of Treponema pallidum subspecies pallidum: an in-vitro study
|
Tantalo, Lauren C
|
|
|
|
12 |
p. e994-e1004
|
artikel
|
| 4 |
A trial of a typhoid conjugate vaccine in children in Malawi
|
Venkatesan, Priya
|
|
|
|
12 |
p. e654
|
artikel
|
| 5 |
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
|
Derendinger, Brigitta
|
|
|
|
12 |
p. e972-e982
|
artikel
|
| 6 |
Comparative neutralisation profile of SARS-CoV-2 omicron subvariants BA.2.75 and BA.5
|
Tan, Chee-Wah
|
|
|
|
12 |
p. e898
|
artikel
|
| 7 |
Correction to Lancet Microbe 2022; 3: e846–56
|
|
|
|
|
12 |
p. e901
|
artikel
|
| 8 |
Current monkeypox outbreak: lessons from ancient history in Egyptian mummies?
|
Farahat, Ramadan Abdelmoez
|
|
|
|
12 |
p. e899
|
artikel
|
| 9 |
Diagnostic performances of common nucleic acid tests for SARS-CoV-2 in hospitals and clinics: a systematic review and meta-analysis
|
Au, Wing Ying
|
|
|
|
12 |
p. e704-e714
|
artikel
|
| 10 |
Does cefiderocol heteroresistance explain the discrepancy between the APEKS-NP and CREDIBLE-CR clinical trial results?
|
Choby, Jacob E
|
|
|
|
12 |
p. e648-e649
|
artikel
|
| 11 |
Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial
|
Dale, Adam P
|
|
|
|
12 |
p. e931-e943
|
artikel
|
| 12 |
Effect of resistance to third-generation cephalosporins on morbidity and mortality from bloodstream infections in Blantyre, Malawi: a prospective cohort study
|
Lester, Rebecca
|
|
|
|
12 |
p. e922-e930
|
artikel
|
| 13 |
Efficacy of phage therapy in preclinical models of bacterial infection: a systematic review and meta-analysis
|
Gómez-Ochoa, Sergio Alejandro
|
|
|
|
12 |
p. e956-e968
|
artikel
|
| 14 |
Emerging bedaquiline-resistant tuberculosis
|
Lange, Christoph
|
|
|
|
12 |
p. e964-e965
|
artikel
|
| 15 |
Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group
|
Baker, Kate S
|
|
|
|
12 |
p. e1035-e1039
|
artikel
|
| 16 |
Evolution and spread of Plasmodium falciparum mutations associated with resistance to sulfadoxine–pyrimethamine in central Africa: a cross-sectional study
|
Guémas, Emilie
|
|
|
|
12 |
p. e983-e993
|
artikel
|
| 17 |
Exploiting genomics for antimicrobial resistance surveillance at One Health interfaces
|
Muloi, Dishon M
|
|
|
|
12 |
p. e1056-e1062
|
artikel
|
| 18 |
From HPV to COVID-19 and beyond: leveraging the power of serology and standards
|
Hempel, Heidi A
|
|
|
|
12 |
p. e966-e967
|
artikel
|
| 19 |
Genetic and phenotypic stability of poliovirus shed from infants who received novel type 2 or Sabin type 2 oral poliovirus vaccines in Panama: an analysis of two clinical trials
|
Wahid, Rahnuma
|
|
|
|
12 |
p. e912-e921
|
artikel
|
| 20 |
Genomics for antimicrobial resistance surveillance to support infection prevention and control in health-care facilities
|
Jauneikaite, Elita
|
|
|
|
12 |
p. e1040-e1046
|
artikel
|
| 21 |
Genomics for public health and international surveillance of antimicrobial resistance
|
Baker, Kate S
|
|
|
|
12 |
p. e1047-e1055
|
artikel
|
| 22 |
Henipavirus naming and regional discrimination
|
Zhai, Shao-Lun
|
|
|
|
12 |
p. e969
|
artikel
|
| 23 |
High prevalence and global distribution of fosfomycin resistance genes in Salmonella serovars
|
Monte, Daniel F M
|
|
|
|
12 |
p. e968
|
artikel
|
| 24 |
Identification of antibiotic pairs with disjoint resistance: innovative progress made but questions remain
|
Nuckchady, Dooshanveer C
|
|
|
|
12 |
p. e652
|
artikel
|
| 25 |
Identification of antibiotic pairs with disjoint resistance: innovative progress made but questions remain
|
Zhang, Huan
|
|
|
|
12 |
p. e651
|
artikel
|
| 26 |
Identification of antibiotic pairs with disjoint resistance: innovative progress made but questions remain – Authors' reply
|
Wright, Erik S
|
|
|
|
12 |
p. e653
|
artikel
|
| 27 |
Identification of immunodominant Bartonella bacilliformis proteins: a combined in-silico and serology approach
|
Dichter, Alexander A
|
|
|
|
12 |
p. e685-e694
|
artikel
|
| 28 |
Immune-mediated attenuation of influenza illness after infection: opportunities and challenges
|
Patel, Manish M
|
|
|
|
12 |
p. e715-e725
|
artikel
|
| 29 |
Immunogenicity of a BNT162b2 vaccine booster in health-care workers
|
Saiag, Esther
|
|
|
|
12 |
p. e650
|
artikel
|
| 30 |
Innovations in genomic antimicrobial resistance surveillance
|
Wheeler, Nicole E
|
|
|
|
12 |
p. e1063-e1070
|
artikel
|
| 31 |
Interaction of Klebsiella pneumoniae with tissue macrophages in a mouse infection model and ex-vivo pig organ perfusions: an exploratory investigation
|
Wanford, Joseph J
|
|
|
|
12 |
p. e695-e703
|
artikel
|
| 32 |
Leveraging genomic surveillance to enhance elimination strategies for hepatitis C virus
|
Tully, Damien C
|
|
|
|
12 |
p. e893-e894
|
artikel
|
| 33 |
Monkeypox and the health-care environment
|
Ogoina, Dimie
|
|
|
|
12 |
p. e889-e890
|
artikel
|
| 34 |
mRNA vaccine against malaria effective in preclinical model
|
Makoni, Munyaradzi
|
|
|
|
12 |
p. e970
|
artikel
|
| 35 |
Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?
|
Sauteur, Patrick M Meyer
|
|
|
|
12 |
p. e897
|
artikel
|
| 36 |
New licences for the COVID-19 Technology Access Pool
|
Venkatesan, Priya
|
|
|
|
12 |
p. e971
|
artikel
|
| 37 |
One world, one health, one virology of the mysterious labyrinth of coronaviruses: the canine coronavirus affair
|
Pratelli, Annamaria
|
|
|
|
12 |
p. e646-e647
|
artikel
|
| 38 |
Paleovirology of monkeypox virus: Egyptian animal mummies should be in focus
|
Saied, AbdulRahman A
|
|
|
|
12 |
p. e900
|
artikel
|
| 39 |
Performance of SARS-CoV-2 nucleic acid amplification testing in Austria as measured by external quality assessment schemes during 3 years of the COVID-19 pandemic: an observational retrospective study
|
Buchta, Christoph
|
|
|
|
12 |
p. e1015-e1023
|
artikel
|
| 40 |
Polio eradication, elusive but achievable
|
The Lancet Microbe,
|
|
|
|
12 |
p. e963
|
artikel
|
| 41 |
Population structure of Salmonella enterica Typhi in Harare, Zimbabwe (2012–19) before typhoid conjugate vaccine roll-out: a genomic epidemiology study
|
Thilliez, Gaetan
|
|
|
|
12 |
p. e1005-e1014
|
artikel
|
| 42 |
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
|
Chemaitelly, Hiam
|
|
|
|
12 |
p. e944-e955
|
artikel
|
| 43 |
Protective efficacy of short-term infection with Necator americanus hookworm larvae in healthy volunteers in the Netherlands: a single-centre, placebo-controlled, randomised, controlled, phase 1 trial
|
Hoogerwerf, Marie-Astrid
|
|
|
|
12 |
p. e1024-e1034
|
artikel
|
| 44 |
Rare recurrences of poliomyelitis in non-endemic countries after eradication: a call for global action
|
Mercader-Barceló, Josep
|
|
|
|
12 |
p. e891-e892
|
artikel
|
| 45 |
Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study
|
Diallo, Mamadou Saliou Kalifa
|
|
|
|
12 |
p. e676-e684
|
artikel
|
| 46 |
The durability of immunity against reinfection by SARS-CoV-2: a comparative evolutionary study
|
Townsend, Jeffrey P
|
|
|
|
12 |
p. e666-e675
|
artikel
|
| 47 |
The effect of live attenuated influenza vaccine on pneumococcal colonisation densities among children aged 24–59 months in The Gambia: a phase 4, open label, randomised, controlled trial
|
Peno, Chikondi
|
|
|
|
12 |
p. e656-e665
|
artikel
|
| 48 |
The gut mycobiome in health, disease, and clinical applications in association with the gut bacterial microbiome assembly
|
Zhang, Fen
|
|
|
|
12 |
p. e969-e983
|
artikel
|
| 49 |
Trachoma elimination targets missed in Australia
|
Barksby, Rebecca
|
|
|
|
12 |
p. e903
|
artikel
|
| 50 |
Universal flu vaccine protects against influenza A and B
|
Feranmi, Folahan
|
|
|
|
12 |
p. e902
|
artikel
|
| 51 |
Vaccines need equity to really work
|
The Lancet Microbe,
|
|
|
|
12 |
p. e888
|
artikel
|
| 52 |
Zimbabwe tackles typhoid and cholera through vaccination
|
Bagcchi, Sanjeet
|
|
|
|
12 |
p. e655
|
artikel
|
| 53 |
Zoonotic Acinetobacter baumannii: the need for genomic epidemiology in a One Health context
|
Castillo-Ramírez, Santiago
|
|
|
|
12 |
p. e895-e896
|
artikel
|
Tijdschrift beschrijving